Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 07, 2020 Filed May 8, 2020 20:20 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 4,470 | $91.05 | $406,993.50 |
DisclosureSEC source: 0001209191-20-027890 · doc4.xml · nonDerivative · entry 3 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,841 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2020 Filed May 8, 2020 20:20 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 35,499 | $96.87 | $3,438,788.13 |
DisclosureSEC source: 0001209191-20-027890 · doc4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,371 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2020 Filed May 8, 2020 20:20 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 24,216 | $187.53 | $4,541,226.48 |
DisclosureSEC source: 0001209191-20-027890 · doc4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,872 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2020 Filed May 8, 2020 20:24 UTC |
SACHS BRUCE IDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $81.54 | $0.00 |
DisclosureSEC source: 0001209191-20-027901 · doc4.xml · derivative · entry 10 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,500 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Fully vested. Read SEC document |
| May 07, 2020 Filed May 8, 2020 20:24 UTC |
SACHS BRUCE IDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $59.55 | $0.00 |
DisclosureSEC source: 0001209191-20-027901 · doc4.xml · derivative · entry 9 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,500 shares Expires 2022-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Fully vested. Read SEC document |
| May 07, 2020 Filed May 8, 2020 20:24 UTC |
SACHS BRUCE IDirector
|
SaleCommon Stock | 2,960 | $272.46 | $806,481.60 |
DisclosureSEC source: 0001209191-20-027901 · doc4.xml · nonDerivative · entry 8 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,210 F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F8 · price: Open market sales reported on this line occurred at a weighted average price of $272.46 (range $272.21 to $272.94). Read SEC document |
| May 07, 2020 Filed May 8, 2020 20:24 UTC |
SACHS BRUCE IDirector
|
SaleCommon Stock | 6,232 | $271.63 | $1,692,798.16 |
DisclosureSEC source: 0001209191-20-027901 · doc4.xml · nonDerivative · entry 7 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,170 F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $271.63 (range $271.17 to $272.14). Read SEC document |
| May 07, 2020 Filed May 8, 2020 20:24 UTC |
SACHS BRUCE IDirector
|
SaleCommon Stock | 5,889 | $270.49 | $1,592,915.61 |
DisclosureSEC source: 0001209191-20-027901 · doc4.xml · nonDerivative · entry 6 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,402 F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $270.49 (range $270.09 to $271.08). Read SEC document |
| May 07, 2020 Filed May 8, 2020 20:24 UTC |
SACHS BRUCE IDirector
|
SaleCommon Stock | 15,751 | $269.53 | $4,245,367.03 |
DisclosureSEC source: 0001209191-20-027901 · doc4.xml · nonDerivative · entry 5 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,291 F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $269.53 (range $269.06 to $270.04). Read SEC document |
| May 07, 2020 Filed May 8, 2020 20:24 UTC |
SACHS BRUCE IDirector
|
SaleCommon Stock | 11,568 | $268.65 | $3,107,743.20 |
DisclosureSEC source: 0001209191-20-027901 · doc4.xml · nonDerivative · entry 4 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,042 F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $268.65 (range $268.06 to $269.03). Read SEC document |
| May 07, 2020 Filed May 8, 2020 20:24 UTC |
SACHS BRUCE IDirector
|
SaleCommon Stock | 2,600 | $267.50 | $695,500.00 |
DisclosureSEC source: 0001209191-20-027901 · doc4.xml · nonDerivative · entry 3 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,610 F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $267.50 (range $267.06 to $268.03). F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 07, 2020 Filed May 8, 2020 20:24 UTC |
SACHS BRUCE IDirector
|
Exercise / conversionCommon Stock | 22,500 | $81.54 | $1,834,650.00 |
DisclosureSEC source: 0001209191-20-027901 · doc4.xml · nonDerivative · entry 2 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2020 Filed May 8, 2020 20:24 UTC |
SACHS BRUCE IDirector
|
Exercise / conversionCommon Stock | 22,500 | $59.55 | $1,339,875.00 |
DisclosureSEC source: 0001209191-20-027901 · doc4.xml · nonDerivative · entry 1 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,710 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:17 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,222 | $0.00 Strike: $155.57 | $0.00 |
DisclosureSEC source: 0001209191-20-027880 · doc4.xml · derivative · entry 6 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,561 Underlying: Common Stock · 1,222 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2018. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:17 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 280 | $274.35 | $76,818.00 |
DisclosureSEC source: 0001209191-20-027880 · doc4.xml · nonDerivative · entry 5 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,902 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $274.35 (range $274.07 to $274.73). Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:17 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 461 | $273.45 | $126,060.45 |
DisclosureSEC source: 0001209191-20-027880 · doc4.xml · nonDerivative · entry 4 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,182 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $273.45 (range $273.00 to $273.96). Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:17 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 210 | $271.87 | $57,092.70 |
DisclosureSEC source: 0001209191-20-027880 · doc4.xml · nonDerivative · entry 3 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,643 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $271.87 (range $271.55 to $272.28). Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:17 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 271 | $270.20 | $73,224.20 |
DisclosureSEC source: 0001209191-20-027880 · doc4.xml · nonDerivative · entry 2 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,853 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $270.20 (range $269.87 to $270.75). F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:17 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Exercise / conversionCommon Stock | 1,222 | $155.57 | $190,106.54 |
DisclosureSEC source: 0001209191-20-027880 · doc4.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:19 UTC |
Kewalramani ReshmaDirector · CEO & President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 510 | $0.00 Strike: $155.57 | $0.00 |
DisclosureSEC source: 0001209191-20-027885 · doc4.xml · derivative · entry 9 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,567 Underlying: Common Stock · 510 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2018. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:19 UTC |
Kewalramani ReshmaDirector · CEO & President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,564 | $0.00 Strike: $187.53 | $0.00 |
DisclosureSEC source: 0001209191-20-027885 · doc4.xml · derivative · entry 8 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,206 Underlying: Common Stock · 1,564 shares Expires 2029-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2019. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:19 UTC |
Kewalramani ReshmaDirector · CEO & President
|
SaleCommon Stock | 134 | $275.17 | $36,872.78 |
DisclosureSEC source: 0001209191-20-027885 · doc4.xml · nonDerivative · entry 7 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,626 F1 · kind: Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $275.17 (range $274.60 to $275.30). Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:19 UTC |
Kewalramani ReshmaDirector · CEO & President
|
SaleCommon Stock | 864 | $274.04 | $236,770.56 |
DisclosureSEC source: 0001209191-20-027885 · doc4.xml · nonDerivative · entry 6 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,760 F1 · kind: Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $274.04 (range $273.56 to $274.40). Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:19 UTC |
Kewalramani ReshmaDirector · CEO & President
|
SaleCommon Stock | 360 | $272.77 | $98,197.20 |
DisclosureSEC source: 0001209191-20-027885 · doc4.xml · nonDerivative · entry 5 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,624 F1 · kind: Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $272.77 (range $272.44 to $273.30). Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:19 UTC |
Kewalramani ReshmaDirector · CEO & President
|
SaleCommon Stock | 300 | $271.92 | $81,576.00 |
DisclosureSEC source: 0001209191-20-027885 · doc4.xml · nonDerivative · entry 4 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,984 F1 · kind: Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $271.92 (range $271.33 to $272.17). Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:19 UTC |
Kewalramani ReshmaDirector · CEO & President
|
SaleCommon Stock | 416 | $270.35 | $112,465.60 |
DisclosureSEC source: 0001209191-20-027885 · doc4.xml · nonDerivative · entry 3 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,284 F1 · kind: Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $270.35 (range $269.87 to $270.75). F3 · price: Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:19 UTC |
Kewalramani ReshmaDirector · CEO & President
|
Exercise / conversionCommon Stock | 510 | $155.57 | $79,340.70 |
DisclosureSEC source: 0001209191-20-027885 · doc4.xml · nonDerivative · entry 2 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:19 UTC |
Kewalramani ReshmaDirector · CEO & President
|
Exercise / conversionCommon Stock | 1,564 | $187.53 | $293,296.92 |
DisclosureSEC source: 0001209191-20-027885 · doc4.xml · nonDerivative · entry 1 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:22 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,222 | $0.00 Strike: $155.57 | $0.00 |
DisclosureSEC source: 0001209191-20-027894 · doc4.xml · derivative · entry 7 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,561 Underlying: Common Stock · 1,222 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2018. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:22 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
SaleCommon Stock | 70 | $274.73 | $19,231.10 |
DisclosureSEC source: 0001209191-20-027894 · doc4.xml · nonDerivative · entry 6 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,838 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:22 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
SaleCommon Stock | 420 | $273.96 | $115,063.20 |
DisclosureSEC source: 0001209191-20-027894 · doc4.xml · nonDerivative · entry 5 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,908 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $273.96 (range $273.68 to $274.31). Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:22 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
SaleCommon Stock | 319 | $273.00 | $87,087.00 |
DisclosureSEC source: 0001209191-20-027894 · doc4.xml · nonDerivative · entry 4 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,328 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $273.00 (range $272.66 to $273.44). Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:22 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
SaleCommon Stock | 140 | $271.64 | $38,029.60 |
DisclosureSEC source: 0001209191-20-027894 · doc4.xml · nonDerivative · entry 3 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,647 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $271.64 (range $271.55 to $271.73). Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:22 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
SaleCommon Stock | 273 | $270.16 | $73,753.68 |
DisclosureSEC source: 0001209191-20-027894 · doc4.xml · nonDerivative · entry 2 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,787 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $270.16 (range $269.77 to $270.75). F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:22 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
Exercise / conversionCommon Stock | 1,222 | $155.57 | $190,106.54 |
DisclosureSEC source: 0001209191-20-027894 · doc4.xml · nonDerivative · entry 1 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:23 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 669 | $0.00 Strike: $131.89 | $0.00 |
DisclosureSEC source: 0001209191-20-027897 · doc4.xml · derivative · entry 5 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,665 Underlying: Common Stock · 669 shares Expires 2025-07-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:23 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
SaleCommon Stock | 669 | $275.28 | $184,162.32 |
DisclosureSEC source: 0001209191-20-027897 · doc4.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,103 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $275.28 (range $275.10 to $275.41). F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:23 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
Exercise / conversionCommon Stock | 669 | $131.89 | $88,234.41 |
DisclosureSEC source: 0001209191-20-027897 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,772 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:28 UTC |
Tatsis OuraniaEVP, Chief Regulatory Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 407 | $0.00 Strike: $155.57 | $0.00 |
DisclosureSEC source: 0001209191-20-027906 · doc4.xml · derivative · entry 10 Tatsis Ourania · CIK 0001789815 · EVP, Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,854 Underlying: Common Stock · 407 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2018. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:28 UTC |
Tatsis OuraniaEVP, Chief Regulatory Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 559 | $0.00 Strike: $187.53 | $0.00 |
DisclosureSEC source: 0001209191-20-027906 · doc4.xml · derivative · entry 9 Tatsis Ourania · CIK 0001789815 · EVP, Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,145 Underlying: Common Stock · 559 shares Expires 2029-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2019. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:28 UTC |
Tatsis OuraniaEVP, Chief Regulatory Officer
|
SaleCommon Stock | 30 | $275.30 | $8,259.00 |
DisclosureSEC source: 0001209191-20-027906 · doc4.xml · nonDerivative · entry 8 Tatsis Ourania · CIK 0001789815 · EVP, Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,738 F1 · kind: Transaction made pursuant to Ms. Tatsis' company-approved trading plan under Rule 10b5-1. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:28 UTC |
Tatsis OuraniaEVP, Chief Regulatory Officer
|
SaleCommon Stock | 330 | $274.13 | $90,462.90 |
DisclosureSEC source: 0001209191-20-027906 · doc4.xml · nonDerivative · entry 7 Tatsis Ourania · CIK 0001789815 · EVP, Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,768 F1 · kind: Transaction made pursuant to Ms. Tatsis' company-approved trading plan under Rule 10b5-1. F3 · price: Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $274.13 (range $273.75 to $274.73). Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:28 UTC |
Tatsis OuraniaEVP, Chief Regulatory Officer
|
SaleCommon Stock | 210 | $273.15 | $57,361.50 |
DisclosureSEC source: 0001209191-20-027906 · doc4.xml · nonDerivative · entry 6 Tatsis Ourania · CIK 0001789815 · EVP, Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,098 F1 · kind: Transaction made pursuant to Ms. Tatsis' company-approved trading plan under Rule 10b5-1. F3 · price: Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $273.15 (range $272.73 to $273.50). Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:28 UTC |
Tatsis OuraniaEVP, Chief Regulatory Officer
|
SaleCommon Stock | 217 | $272.09 | $59,043.53 |
DisclosureSEC source: 0001209191-20-027906 · doc4.xml · nonDerivative · entry 5 Tatsis Ourania · CIK 0001789815 · EVP, Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,308 F1 · kind: Transaction made pursuant to Ms. Tatsis' company-approved trading plan under Rule 10b5-1. F3 · price: Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $272.09 (range $271.73 to $272.54). Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:28 UTC |
Tatsis OuraniaEVP, Chief Regulatory Officer
|
SaleCommon Stock | 136 | $270.19 | $36,745.84 |
DisclosureSEC source: 0001209191-20-027906 · doc4.xml · nonDerivative · entry 4 Tatsis Ourania · CIK 0001789815 · EVP, Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,525 F1 · kind: Transaction made pursuant to Ms. Tatsis' company-approved trading plan under Rule 10b5-1. F3 · price: Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $270.19 (range $269.71 to $270.61). Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:28 UTC |
Tatsis OuraniaEVP, Chief Regulatory Officer
|
SaleCommon Stock | 43 | $268.80 | $11,558.40 |
DisclosureSEC source: 0001209191-20-027906 · doc4.xml · nonDerivative · entry 3 Tatsis Ourania · CIK 0001789815 · EVP, Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,661 F1 · kind: Transaction made pursuant to Ms. Tatsis' company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $268.80 (range $268.65 to $269.12). F3 · price: Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:28 UTC |
Tatsis OuraniaEVP, Chief Regulatory Officer
|
Exercise / conversionCommon Stock | 407 | $155.57 | $63,316.99 |
DisclosureSEC source: 0001209191-20-027906 · doc4.xml · nonDerivative · entry 2 Tatsis Ourania · CIK 0001789815 · EVP, Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:28 UTC |
Tatsis OuraniaEVP, Chief Regulatory Officer
|
Exercise / conversionCommon Stock | 559 | $187.53 | $104,829.27 |
DisclosureSEC source: 0001209191-20-027906 · doc4.xml · nonDerivative · entry 1 Tatsis Ourania · CIK 0001789815 · EVP, Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:26 UTC |
Silva Paul MSVP & Controller
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 611 | $0.00 Strike: $155.57 | $0.00 |
DisclosureSEC source: 0001209191-20-027904 · doc4.xml · derivative · entry 11 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,281 Underlying: Common Stock · 611 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2018. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:26 UTC |
Silva Paul MSVP & Controller
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 465 | $0.00 Strike: $187.53 | $0.00 |
DisclosureSEC source: 0001209191-20-027904 · doc4.xml · derivative · entry 10 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,122 Underlying: Common Stock · 465 shares Expires 2029-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.